Search
Search Constraints
You searched for: Author/Creator Marks, SLimit your search
- Marks, S [remove] 7
- Infants -- Diseases -- Periodicals 5
- 618.920005 3
- Children -- Diseases -- Periodicals 3
- 618.920105 2
- Fetus -- Diseases -- Periodicals 2
- Newborn infants -- Diseases -- Periodicals 2
- 616.99424 1
- 617.1027 1
- ADC Antibody drug conjugates -- ADCC Antibody-dependent cell-mediated cytotoxicity -- ADCP Antibody-dependent cell-mediated phagocytosis -- ALK Anaplastic lymphoma kinase -- AMT Aminomethytransferase -- APC Antigen-presenting cells -- ATE Antibody-triggered endocytosis -- AXL AXL tyrosine receptor kinase -- BRAF V-raf murine sarcoma viral oncogene homolog B1 -- bsADC Bispecific antibody drug conjugate -- C1q Completment component 1q -- C797S Cysteine substitution to Serine at codon 797 (exon 19 EGFR gene) -- CAB Conditionally active biologic -- CD Cluster of differentiation -- CDK4/6 Cyclin-dependent kinase(s) 4/6 -- CEA Carcinoembryonic antigen -- EACAM5 CEA cell adhesion molecule 5 -- c-MET Tyrosine-protein kinase Met (Hepatocyte growth factor receptor HGFR) -- CTLA-4 Cytotoxic T-lymphocyte-associated protein 4 -- DAR Drug-antibody ratio -- DCR Disease control rate -- DLL3 Delta-like 3 protein -- DM1 Emtansine -- DM4 Ravtansine -- DOR Duration of response -- DS-8201 Trastuzumab-deruxtecan -- EGFR Epithelial growth factor receptor -- EpCAM Epithelial cell adhesion molecule -- EML4-ALK Echinoderm microtubule-associated protein-like 4 with ALK (fusion protein) -- ERBB2 Erb-B2 Receptor Tyrosine Kinase 2 -- ESMO European Society of Medical Oncology -- FDA U.S. Food and Drug Administration -- FRα Folate receptor alpha -- FOXO3α Forkhead box O3α -- HER2 Human epidermal growth factor receptor 2 -- HER3 Human epidermal growth factor receptor 3 -- HER3-DXd Patritumab-deruxtecan -- ICI Immune checkpoint inhibito -- IHC Immunohistochemistry -- ILD Interstitial lung disease -- ISAC mmune stimulatory drug conjugate -- L858R Leucine substitution to Arginine at position 858 (exon 21 EGFR gene) -- LIFR Leukaemia inhibitory factor receptor -- 177Lu Lutetium-177 (isotope) -- Ly6E Lymphocyte antigen 6 family member E -- mAb Monoclonal antibody -- MAPK Mitogen-activated protein kinase -- MC Maleimidoca-propyl (linker) -- MCC Maleimidomethyl cyclohexane-1-carboxylate (linker) -- MET MET proto-oncogene receptor tyrosine kinase -- MMAE Monomethyl auristatin E -- MMAF Monomethyl auristatin F -- MT1-MMP/MMP14 Membrane type 1 matrix metalloproteinase -- MUC4 Mucin 4 cell surface associated protein coding gene -- 277Th Thorium-277 (sotope) -- mTOR Mammalian target of rapamycin protein -- NaPi2b Sodium-dependent phosphate transport protein 2B -- NCCN National Comprehensive Cancer Network -- NE Not evaluable -- NGS Next generation sequencing -- NSCLC Non-small cell lung cancer -- NTRK Neurotrophic Tyrosine Kinase (fusion) -- ORR Overall response rate -- P-gp-MDR1 P-glycoprotein 1 (Multi-drug resistant) -- p95HER2 p95 truncated HER2 receptor -- PD1 Programmed cell death protein 1 -- PD-L1 Programmed death ligand 1 -- PFS Progression free survival -- PI3K Phosphoinositide 3-kinase -- PLK1 Serine/threonine-protein kinase 1 (Polo-like kinase 1) -- PTK7 Tyrosine-protein kinase-like 7 (Colon carcinoma kinase 4) -- PVRL4 Poliovirus-receptor-like 4 (Nectin4) -- Raf Rapidly accelerated fibrosarcoma (gene) -- Ras Rat sarcoma virus (gene) -- RET 'Rearrangement during transfection' proto-oncogene receptor tyrosine kinase -- RIC Radioimmunoconjugate -- ROS c-ros oncogene (rearrangement) -- Rova-T Rovalpituzumab-tesirine -- RTK Receptor tyrosine kinase -- SAR408701 Tusamitamab-Ravtansine -- SLC46A3 Solute carrier family 46 member 3 (protein) -- STAT3 Signal transducer and activator of transcription 3 -- T790M Threonine substitution to methionine at position 790 (exon 20EGFR gene) -- T-DM1 Trastuzumab-emtansine -- TKI Tyrosine kinase inhibitor -- TLR Toll-like receptor -- TME Tumour microenvironment -- TROP2 Tumour-associated calcium signal transducer 2 (gene) -- TUBB3 Tubulin Beta 3 Class 3 (protein) -- U3-1402 Patritumab-deruxteca -- VEGF2 Vascular endothelial growth factor 2 1
- Electronic journals 1